Clinical Trials
2 trialsNCT00361088 2013-11-25
A Combination of Zarnestra With Velcade for Patients With Relapsed Multiple Myeloma
H. Lee Moffitt Cancer Center and Research Institute
Phase 1/2 Terminated
NCT00243035 2013-10-08
Tipifarnib and Bortezomib in Treating Patients With Relapsed Multiple Myeloma
National Cancer Institute (NCI)
Phase 1/2 Terminated